glycyrrhizic acid has been researched along with mocetinostat in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, MB; Kilgore, KS; Lucchesi, BR; Naylor, KB; Park, JL; Tanhehco, EJ | 1 |
| Feng, YT; Ji, WS; Jiao, JX; Sun, LH; Wu, KX; Yuan, H | 1 |
| Nakata, N; Takaoka, K | 1 |
| Fujimura, Y; Kano, Y; Kawashima, K; Makino, T | 1 |
| Chen, JQ; Jiang, RA; Mao, LG; Qian, Y; Tang, HF | 1 |
| Crisafulli, C; Cuzzocrea, S; Dal Bosco, M; Di Paola, R; Genovese, T; Mazzon, E; Menegazzi, M; Suzuki, H; Zou, Z | 1 |
| Kang, HS; Kim, CJ; Lee, JY; Moon, HJ; Park, BE; Sim, SS | 1 |
| Cai, TT; Chen, T; Shen, Y; Sun, Y; Xu, Q; Zhou, XB | 1 |
| Chen, JQ; Jiang, RA; Mao, LG; Qian, Y; Shi, JR; Tang, HF | 1 |
| Fu, HY; Jiang, T; Kuai, JK; Lu, ZF; Ni, YF; Tian, F; Wang, J; Wang, YJ; Yan, XL; Yang, GD; Zhao, YC | 1 |
| Kudo, T; Masuo, T; Mori, M; Okamura, S; Zhang, Y | 1 |
| Fu, Y; Guo, M; Liang, D; Wang, T; Wang, W; Wei, Z; Yang, Z; Zhang, N; Zhou, E | 1 |
| Lian, A; Shi, Z; Zhang, F | 1 |
| Fang, M; Fei, X; Gong, F; Hua, S; Ma, M; Zhang, Y | 1 |
| Bi, H; Cao, P; Chen, N; Chu, S; Guo, Q; He, W; Li, F; Li, X; Niu, Z; Sun, X; Zhang, Z | 1 |
15 other study(ies) available for glycyrrhizic acid and mocetinostat
| Article | Year |
|---|---|
Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics.
Topics: Animals; Cell Adhesion; Glycyrrhizic Acid; Humans; Immunohistochemistry; Leukocyte Count; Myocardial Infarction; Neutrophils; P-Selectin; Peroxidase; Rabbits | 1998 |
Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Disease Models, Animal; Female; Gene Expression Regulation; Glycyrrhizic Acid; Intercellular Adhesion Molecule-1; Intestinal Mucosa; NF-kappa B; Peroxidase; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2006 |
Use of glycyrrhizin in prevention of tissue damage caused by ischemia-reperfusion in rabbit hind limbs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillaries; Edema; Endothelium, Vascular; Glycyrrhizic Acid; Hindlimb; Peroxidase; Rabbits; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selectins | 2006 |
Pharmacological properties of traditional medicine (XXXII): protective effects of hangeshashinto and the combinations of its major constituents on gastric lesions in rats.
Topics: Animals; Berberine; Drugs, Chinese Herbal; Ethanol; Flavonoids; Gastric Mucosa; Glycyrrhizic Acid; Male; Panax; Peroxidase; Rats; Rats, Wistar | 2006 |
[Protective effect against monoammonium glycyrrhizinate on lipopolysaccharide-induced acute lung injury in mice].
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Glycyrrhizic Acid; Interleukin-10; Leukocyte Count; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred ICR; Neutrophils; Organ Size; Peroxidase; Protective Agents; Tumor Necrosis Factor-alpha | 2007 |
Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model.
Topics: Animals; Anti-Inflammatory Agents; Electroencephalography; Gastrointestinal Tract; Glycyrrhizic Acid; Hypertension; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interleukin-1beta; Male; Malondialdehyde; Neutrophils; P-Selectin; Peroxidase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2009 |
Inhibitory effects of Geijigajakyak-Tang on trinitrobenzene sulfonic acid-induced colitis.
Topics: Acrolein; Animals; Anti-Inflammatory Agents; Antioxidants; Benzoates; Bridged-Ring Compounds; Chemotaxis; Colitis; Cyclohexanols; Eucalyptol; Female; Glucosides; Glycyrrhizic Acid; Ileum; Lipid Peroxidation; Magnoliopsida; Malondialdehyde; Mice; Mice, Inbred BALB C; Models, Animal; Monoterpenes; Muscle Contraction; Muscle, Smooth; Neutrophils; Parasympatholytics; Peroxidase; Phytotherapy; Plant Extracts; Saponins; Trinitrobenzenesulfonic Acid; Triterpenes | 2009 |
Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance.
Topics: Animals; Body Weight; Colitis; Colon; Crohn Disease; Cytokines; Diarrhea; Disease Models, Animal; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Humans; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Peroxidase; Trinitrobenzenesulfonic Acid | 2009 |
Monoammonium glycyrrhizinate inhibited the inflammation of LPS-induced acute lung injury in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Cyclic AMP; Glycyrrhizic Acid; Inflammation; Interleukin-10; Lipopolysaccharides; Lung Diseases; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Neutrophils; Oxidation-Reduction; Peroxidase; Phosphoric Diester Hydrolases; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2010 |
Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression.
Topics: Acute Lung Injury; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Glycyrrhizic Acid; Interleukin-1beta; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxidase; Tumor Necrosis Factor-alpha | 2011 |
Topical application of glycyrrhizin preparation ameliorates experimentally induced colitis in rats.
Topics: Administration, Topical; Animals; Carboxymethylcellulose Sodium; Colitis; Cytokines; Dextran Sulfate; Enema; Glycyrrhizic Acid; Male; Peroxidase; Rats; Rats, Wistar | 2011 |
Glycyrrhizin inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model.
Topics: Animals; Cell Survival; Disease Models, Animal; Epithelial Cells; Glycyrrhizic Acid; Interleukin-1beta; Interleukin-6; Mammary Glands, Animal; Mastitis; Mice; NF-kappa B; Peroxidase; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
Nuclear factor-κB activation inhibitor attenuates ischemia reperfusion injury and inhibits Hmgb1 expression.
Topics: Animals; Apoptosis; Benzamides; Cyclohexanones; Glycyrrhizic Acid; Heart Transplantation; HMGB1 Protein; Male; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Neutrophil Infiltration; NF-kappa B; Peroxidase; Reperfusion Injury; Troponin T | 2014 |
Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis Regulatory Proteins; Glycyrrhizic Acid; HMGB1 Protein; Interleukin-1beta; Intracellular Signaling Peptides and Proteins; Kupffer Cells; Liver; Liver Diseases; Male; Mice, Inbred C57BL; Peroxidase; Phosphate-Binding Proteins; Pyroptosis; Reperfusion Injury | 2019 |
Combination of monoammonium glycyrrhizinate and cysteine hydrochloride ameliorated lipopolysaccharide/galactosamine-induced acute liver injury through Nrf2/ARE pathway.
Topics: Animals; Antioxidant Response Elements; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cysteine; Cytokines; Drug Combinations; Galactosamine; Glutathione; Glycyrrhizic Acid; Heme Oxygenase-1; Hepatocytes; Lipopolysaccharides; Liver; Male; Malondialdehyde; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Peroxidase; Signal Transduction; Superoxide Dismutase | 2020 |